findmyKOL
Clinical trialNCT02058290TerminatedPhase 4Interventional

A Health Economic Trial in Adult Patients Undergoing Laparoscopic Colectomy

SponsorPacira Pharmaceuticals, IncEnrollment122Bowel Obstruction
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is designed to compare the standard of care against EXPAREL (bupivacaine liposome injectable suspension) to determine if total opioid consumption is reduced when using EXPAREL, therefore possibly reducing total hospital costs.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Washington Hospital Center

    Washington D.C., District of Columbia, United States

  • University of Miami, Dept. Anesthesiology

    Miami, Florida, United States

  • Tampa General Hospital

    Tampa, Florida, United States

  • Albany Medical College

    Albany, New York, United States

  • the Ohio State University Medical Center

    Columbus, Ohio, United States

  • Methodist Hospital

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Bupivacaine →IV morphine sulfate or Sponsor-approved equivalent
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2011
Primary completion
30 Sept 2012
Completion
28 Feb 2013
Last update posted
14 May 2014
Registered enrollment
122
Registry id
NCT02058290
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.